http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I765908-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7e2b9a11a3f71d165e7dd72230437a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f41ad3e3eb895fb77774c608c6e8eeb7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12fd3e2d2b2aab27ebf485b40921d79a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83489ea03d15d42182c1c4692a5bf3ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df972d955839c938c95150486225137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afbbadf2b1455d0618bc6e404cde884d
publicationDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-I765908-B
titleOfInvention Benzimidazole compounds as kinase inhibitors, and preparation methods and applications thereof
abstract The present invention relates to benzimidazole compounds as kinase inhibitors, and preparation methods and applications thereof. In particular, the present invention relates to benzimidazole compounds represented by general formula(I), their preparation methods and pharmaceutical compositions, and their applications as kinase inhibitors in the preparation of drugs. The drugs can prevent and / or treat diseases related to cancer or tumor, especially bladder cancer, ovarian cancer, peritoneal cancer, pancreatic cancer, breast cancer, uterine cancer, cervical cancer, endometrial cancer, prostate cancer, female genital tract cancer, testicular cancer, gastrointestinal stromal tumors, and are expected to develop into a new generation of benzimidazole compounds as kinase inhibitor drugs. Each substituent in the general formula (I) is defined as that in the specification.
priorityDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105294683-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102264725-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341

Total number of triples: 30.